Larimar Therapeutics (LRMR) Q1 2023 Earnings

15MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.57
-0.43
-0.29
-0.15

Details

Expected EPS
-0.25
Actual EPS
-0.15
Surprise EPS
0.1
Surprise Percent
+40%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.15 per share for Q1 2023.

0 Comments

Share your thoughts